• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Novanta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8/5/25 8:00:38 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous
    Get the next $NOVT alert in real time by email
    8-K
    0001076930false00010769302025-08-052025-08-05

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): August 5, 2025

    NOVANTA INC.

    (Exact name of registrant as specified in is charter)

    New Brunswick, Canada

    001-35083

    98-0110412

    (State or other jurisdiction

    of incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

     

     

    125 Middlesex Turnpike

    Bedford, Massachusetts

    01730

    (Address of principal executive offices)

    (Zip Code)

    Registrant’s telephone number, including area code: (781) 266-5700

    Not Applicable

    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange on which registered

    Common shares, no par value

     

    NOVT

     

    Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


     

    Item 2.02 Results of Operations and Financial Condition.

    On August 5, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 27, 2025. A copy of this press release is attached hereto as Exhibit 99.1.

    The information contained in this Current Report, including Exhibit 99.1, is furnished under this Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing thereunder or under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit

    Number

    Description

     99.1

    Press Release, dated August 5, 2025

     104

     Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Novanta Inc.

    Date: August 5, 2025

    By:

    /s/ Robert J. Buckley

    Robert J. Buckley

    Chief Financial Officer

     

     

     

     


    Get the next $NOVT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NOVT

    DatePrice TargetRatingAnalyst
    5/11/2022Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NOVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladone Mary Kay converted options into 572 shares (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    7/14/25 4:39:06 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Director Johnson Robert Matthew converted options into 818 shares (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    5/12/25 4:05:51 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Co-Chief Operating Officer Ravetto Charles Guy Jr converted options into 9,421 shares and covered exercise/tax liability with 3,418 shares, increasing direct ownership by 84% to 13,162 units (SEC Form 4)

    4 - NOVANTA INC (0001076930) (Issuer)

    4/23/25 6:14:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    SEC Filings

    View All

    SEC Form 10-Q filed by Novanta Inc.

    10-Q - NOVANTA INC (0001076930) (Filer)

    8/5/25 9:31:01 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NOVANTA INC (0001076930) (Filer)

    8/5/25 8:00:38 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. filed SEC Form 8-K: Leadership Update

    8-K - NOVANTA INC (0001076930) (Filer)

    7/11/25 4:30:28 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and adv

    8/12/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the Second Quarter 2025

    Second Quarter 2025 GAAP Revenue increased 2% to $241 million Second Quarter 2025 GAAP Net Income of $4.5 million Second Quarter 2025 GAAP Diluted Earnings Per Share of $0.12 Second Quarter 2025 Adjusted EBITDA of $52 million Second Quarter 2025 Adjusted EPS of $0.76 Company updates Full Year 2025 financial guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) June 27,     June 28,

    8/5/25 6:55:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025. The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the call

    7/8/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Novanta upgraded by William Blair

    William Blair upgraded Novanta from Mkt Perform to Outperform

    5/11/22 6:19:56 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Financials

    Live finance-specific insights

    View All

    Novanta Announces Financial Results for the Second Quarter 2025

    Second Quarter 2025 GAAP Revenue increased 2% to $241 million Second Quarter 2025 GAAP Net Income of $4.5 million Second Quarter 2025 GAAP Diluted Earnings Per Share of $0.12 Second Quarter 2025 Adjusted EBITDA of $52 million Second Quarter 2025 Adjusted EPS of $0.76 Company updates Full Year 2025 financial guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amounts) June 27,     June 28,

    8/5/25 6:55:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025. The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the call

    7/8/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    Novanta Announces Financial Results for the First Quarter 2025

    First Quarter 2025 GAAP Revenue increased 1% to $233 million First Quarter 2025 GAAP Diluted Earnings Per Share of $0.59 and Adjusted EPS of $0.74 First Quarter 2025 GAAP Net Income increased 45% to $21 million First Quarter 2025 Adjusted EBITDA increased 1% to $50 million First Quarter 2025 Operating Cash Flow of $32 million Company reiterates Full Year 2025 Adjusted EBITDA guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amoun

    5/6/25 7:00:00 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    $NOVT
    Leadership Updates

    Live Leadership Updates

    View All

    IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

    IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl

    2/20/25 5:07:00 PM ET
    $ATMU
    $IEX
    $NOVT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Fluid Controls
    Industrials

    Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

    Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

    6/26/24 8:00:00 AM ET
    $A
    $ANIK
    $AVNT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical/Dental Instruments
    Health Care

    $NOVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Novanta Inc.

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    11/14/24 1:22:36 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Novanta Inc.

    SC 13G - NOVANTA INC (0001076930) (Subject)

    2/14/24 10:02:59 AM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Novanta Inc. (Amendment)

    SC 13G/A - NOVANTA INC (0001076930) (Subject)

    2/13/24 5:09:44 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous